Kate Farnell

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Evaluation and Management of Thyroid Nodules: A Joint Consensus Statement From the British Thyroid Association (BTA), British Association of Endocrine and Thyroid Surgeons (BAETS) and Collaborating Bodies.

Evaluation and Management of Thyroid Nodules: A Joint Consensus Statement From the British Thyroid Association (BTA), British Association of Endocrine and Thyroid Surgeons (BAETS) and Collaborating Bodies.

Journal: Clinical endocrinology

Published: November 21, 2025

Iodine or Not for Low-risk Differentiated Thyroid Cancer: How Should We Implement the Findings into UK Practice? An Expert Consensus Opinion.

Iodine or Not for Low-risk Differentiated Thyroid Cancer: How Should We Implement the Findings into UK Practice? An Expert Consensus Opinion.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: July 02, 2025

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial.

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial.

Journal: Lancet (London, England)

Published: December 17, 2024

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 11, 2023

A study of variation in therapeutic approach to low-risk differentiated thyroid cancer in the UK.

A study of variation in therapeutic approach to low-risk differentiated thyroid cancer in the UK.

Journal: The Journal of laryngology and otology

Published: May 17, 2023

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.

Journal: European thyroid journal

Published: April 04, 2023

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK.

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 09, 2022

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial.

Journal: BMC cancer

Published: March 21, 2019

Quality of life in differentiated thyroid cancer.

Quality of life in differentiated thyroid cancer.

Journal: International journal of surgery (London, England)

Published: July 31, 2017

Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care.

Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care.

Journal: Hormones (Athens, Greece)

Published: July 01, 2012

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

Journal: The New England journal of medicine

Published: May 04, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026